In the last 20 years, research focused on developing retinal imaging as a source of potential
biomarkers for Alzheimer's disease and other neurodegenerative diseases, has increased …

Alzheimer's Disease (AD) is a devastating neurodegenerative disorder of the brain, clinically
characterised by cognitive deficits that gradually worsen over time. There is, at present, no …

Retinal imaging technology is rapidly advancing and can provide ever-increasing amounts
of information about the structure, function and molecular composition of retinal tissue in …

Background Retinal changes may reflect the pathophysiological processes in the central
nervous system and can be assessed by imaging modalities non-invasively. We aim to …

The retina has been increasingly investigated as a site of Alzheimer's disease (AD)
manifestation for over a decade. Early reports documented degeneration of retinal ganglion …

Amyloid-β (Aβ) accumulations have been identified in the retina for neurodegeneration-
associated disorders like Alzheimer's disease (AD), glaucoma, and age-related macular …

Purpose Although Alzheimer's disease (AD) is a leading cause of dementia worldwide, its
clinical diagnosis remains a challenge. Optical coherence tomography (OCT) and OCT with …

Efficient monitoring of SARS-CoV-2 outbreak requires the use of a sensitive and rapid
diagnostic test. Although SARS-CoV-2 RNA can be detected by RT-qPCR, the molecular …

Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by
neuronal loss, extracellular amyloid-β (Aβ) plaques, and intracellular neurofibrillary tau …

In this study, we report the results of a comprehensive phenotyping of the retina of the App
NL-GF mouse. We demonstrate that soluble Aβ accumulation is present in the retina of these …